Jane Sarginson

1.4k total citations
17 papers, 1.1k citations indexed

About

Jane Sarginson is a scholar working on Molecular Biology, Behavioral Neuroscience and Physiology. According to data from OpenAlex, Jane Sarginson has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Behavioral Neuroscience and 4 papers in Physiology. Recurrent topics in Jane Sarginson's work include Stress Responses and Cortisol (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Smoking Behavior and Cessation (2 papers). Jane Sarginson is often cited by papers focused on Stress Responses and Cortisol (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Smoking Behavior and Cessation (2 papers). Jane Sarginson collaborates with scholars based in United Kingdom, United States and China. Jane Sarginson's co-authors include Greer M. Murphy, Alan F. Schatzberg, Laura C. Lazzeroni, Heather Ryan, Caroline Crombie, Hannes Pétursson, Augustine Kong, Kāri Stefánsson, Phil Yates and Jeffrey R. Gulcher and has published in prestigious journals such as Scientific Reports, The American Journal of Human Genetics and Neuropsychopharmacology.

In The Last Decade

Jane Sarginson

16 papers receiving 1.0k citations

Peers

Jane Sarginson
Orna Tighe Ireland
Johannes Thome United Kingdom
Ari Illi Finland
Khanum Ridler United Kingdom
Jane Sarginson
Citations per year, relative to Jane Sarginson Jane Sarginson (= 1×) peers Thomas Bettecken

Countries citing papers authored by Jane Sarginson

Since Specialization
Citations

This map shows the geographic impact of Jane Sarginson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Sarginson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Sarginson more than expected).

Fields of papers citing papers by Jane Sarginson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Sarginson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Sarginson. The network helps show where Jane Sarginson may publish in the future.

Co-authorship network of co-authors of Jane Sarginson

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Sarginson. A scholar is included among the top collaborators of Jane Sarginson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Sarginson. Jane Sarginson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sarginson, Jane, et al.. (2023). Cognitive function in soccer athletes determined by sleep disruption and self-reported health, yet not by decision-reinvestment. Frontiers in Neurology. 13. 872761–872761. 4 indexed citations
2.
Bradburn, Steven, Jane Sarginson, & Chris Murgatroyd. (2018). Association of Peripheral Interleukin-6 with Global Cognitive Decline in Non-demented Adults: A Meta-Analysis of Prospective Studies. Frontiers in Aging Neuroscience. 9. 438–438. 90 indexed citations
3.
Gonda, Xénia, Jane Sarginson, Nóra Eszlári, et al.. (2017). A new stress sensor and risk factor for suicide: the T allele of the functional genetic variant in the GABRA6 gene. Scientific Reports. 7(1). 12887–12887. 15 indexed citations
4.
Qurashi, Inti, Imran B. Chaudhry, Ameer B. Khoso, et al.. (2017). A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol. Trials. 18(1). 524–524. 12 indexed citations
5.
Sarginson, Jane, Roger T. Webb, Susan Jill Stocks, et al.. (2017). Temporal trends in antidepressant prescribing to children in UK primary care, 2000–2015. Journal of Affective Disorders. 210. 312–318. 38 indexed citations
6.
Sarginson, Jane, Joel D. Killen, Laura C. Lazzeroni, et al.. (2015). Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region. Nicotine & Tobacco Research. 17(9). 1126–1133. 13 indexed citations
7.
Tennakoon, Lakshika, Jennifer Keller, Jane Sarginson, et al.. (2014). ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression. The Pharmacogenomics Journal. 15(4). 332–339. 28 indexed citations
8.
Sarginson, Jane, J.F.W. Deakin, Ian Anderson, et al.. (2014). Neuronal Nitric Oxide Synthase (NOS1) Polymorphisms Interact with Financial Hardship to Affect Depression Risk. Neuropsychopharmacology. 39(12). 2857–2866. 25 indexed citations
9.
Schabetsberger, Robert, Finn Økland, Meelis Tambets, et al.. (2014). Genetic and migratory evidence for sympatric spawning of tropical Pacific eels from Vanuatu. Marine Ecology Progress Series. 521. 171–187. 30 indexed citations
10.
Schatzberg, Alan F., Jennifer Keller, Lakshika Tennakoon, et al.. (2013). HPA axis genetic variation, cortisol and psychosis in major depression. Molecular Psychiatry. 19(2). 220–227. 100 indexed citations
11.
Murphy, Greer M., Jane Sarginson, Heather Ryan, et al.. (2013). BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression. Pharmacogenetics and Genomics. 23(6). 301–313. 40 indexed citations
12.
Sarginson, Jane, Joel D. Killen, Laura C. Lazzeroni, et al.. (2011). Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5‐A3‐B4) predict severity of nicotine addiction and response to smoking cessation therapy. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 156(3). 275–284. 71 indexed citations
13.
Sarginson, Jane, et al.. (2010). ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression. Pharmacogenetics and Genomics. 20(8). 467–475. 69 indexed citations
14.
Sarginson, Jane, Laura C. Lazzeroni, Heather Ryan, Alan F. Schatzberg, & Greer M. Murphy. (2009). FKBP5 polymorphisms and antidepressant response in geriatric depression. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 153B(2). 554–560. 51 indexed citations
15.
Zhang, Feng, et al.. (2006). Genetic association between schizophrenia and the DISC1 gene in the Scottish population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 141B(2). 155–159. 51 indexed citations
16.
Stefánsson, Hreinn, Jane Sarginson, Augustine Kong, et al.. (2003). Association of Neuregulin 1 with Schizophrenia Confirmed in a Scottish Population. The American Journal of Human Genetics. 72(1). 83–87. 428 indexed citations
17.
Sarginson, Jane, et al.. (1985). A Reliable Method of Inducing Placebo Analgesia in Volunteers. Journal of Pharmacy and Pharmacology. 37(Supplement_12). 105P–105P.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026